Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Young Mi Whang"'
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223689 (2019)
PURPOSE:Two-dimensional (2D) cell culture is a valuable method for cell-based research but can provide unpredictable, misleading data about in vivo responses. In this study, we created a three-dimensional (3D) cell culture environment to mimic tumor
Externí odkaz:
https://doaj.org/article/cab1e9b33f544e84becdc16d0d474ac8
Autor:
Young Mi Whang, Ukhyun Jo, Jae Sook Sung, Hyun Jung Ju, Hyun Kyung Kim, Kyong Hwa Park, Jong Won Lee, In Song Koh, Yeul Hong Kim
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53012 (2013)
Wnt5a is overexpressed during the progression of human non-small cell lung cancer. However, the roles of Wnt5a during smoking-related lung carcinogenesis have not been clearly elucidated. We investigated the associations between Wnt5a and the early d
Externí odkaz:
https://doaj.org/article/c42cf90ad23a45fa9d4a8eaa968d9469
Publikováno v:
The Korean Journal of Urological Oncology. 17:88-95
Autor:
Young Mi Whang, Chang Hyun Kim, In Ho Chang, Ho Yub Yoon, Soo-Yeon Kim, Yoon Tae Goo, Seh Hyon Song, Tae Hoon Kang, Sang Jin Lee, Young-Wook Choi
Publikováno v:
International Journal of Nanomedicine. 14:6249-6268
Purpose To develop an intravesical instillation system for the treatment of bladder cancer, rapamycin (Rap) was encapsulated into liposomes and then homogeneously dispersed throughout a poloxamer 407 (P407)-based hydrogel. Methods Rap-loaded conventi
Autor:
In Ho Chang, Young Mi Whang, Byung Hoon Chi, Myeong Joo Kim, Min Ji Cho, Serk In Park, Gwang Yong Hwang
Publikováno v:
Journal of Cellular Biochemistry. 120:19186-19201
Rapamycin is well-recognized in the clinical therapeutic intervention for patients with cancer by specifically targeting mammalian target of rapamycin (mTOR) kinase. Rapamycin regulates general autophagy to clear damaged cells. Previously, we identif
Autor:
In Ho Chang, Sang-Jin Lee, Young Mi Whang, Kijeong Kim, Young Wook Choi, Min-Ji Cho, Myeong Joo Kim
Publikováno v:
Biochemical and Biophysical Research Communications. 509:167-174
Purpose Although Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is the most widely used bladder cancer immunotherapy, innate immune responses involving antimicrobial peptides (AMPs) cause BCG failure and unwanted side effects. Here, we generated
Autor:
Young Wook Choi, In Ho Chang, Hoyub Yoon, Min Ji Cho, Young Mi Whang, Myeong Joo Kim, Tae-Hyoung Kim
Publikováno v:
Journal of Cellular Physiology. 234:13083-13096
Rapamycin, a mammalian target of rapamycin (mTOR) inhibitor, has significant potential for application in the treatment of urothelial carcinoma (URCa) of the bladder. Previous studies have shown that regulation of the AMP-activated serine/threonine p
Autor:
Gwang Yong Hwang, Young Wook Choi, Serk In Park, Young Mi Whang, In Ho Chang, Da Hyeon Yoon, Hoyub Yoon
Publikováno v:
Cancers
Volume 12
Issue 12
Cancers, Vol 12, Iss 3679, p 3679 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3679, p 3679 (2020)
The Mycobacterium Bacillus Calmette-Gué
rin cell wall skeleton (BCG-CWS), the main immune active center of BCG, is a potent candidate non-infectious immunotherapeutic drug and an alternative to live BCG for use against urothelial carcinoma
rin cell wall skeleton (BCG-CWS), the main immune active center of BCG, is a potent candidate non-infectious immunotherapeutic drug and an alternative to live BCG for use against urothelial carcinoma
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 31(5)
Background: Metformin has antitumoral actions in human cancers, including the thyroid, while its effects on metastatic lesions are unclear. Patients with bone metastasis (BM) from thyroid cancers have poor survival. Because metformin inhibits the act
Publikováno v:
The Korean Journal of Urological Oncology. 16:52-57